Automated Cell Culture and Clone Ranking Systems​

Monoclonal antibody therapies: their importance in the pharmaceutical market cannot be overstated. As the demand for new therapeutic antibodies continues to grow, more efficient development of stable cell lines becomes increasingly crucial. With the race against time to bring new therapies to patients for, among other things, cancer and autoimmune diseases, expediting time-to-market is vital. And that requires faster, more effective clone screening.